DePalmer G

Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.

2 preprints · 3 papers

PreprintPsilocybin

Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial

Kelmendi B, Adams T, Ching THW +16

Europe PMC2026
ArticlePsilocybin

Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.

Ching THW, Stahnke B, Shnayder S +22

Europe PMC2025
ArticlePsilocybin

Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.

Ching THW, Grazioplene R, Bohner C +14

Europe PMC2023
ArticlePsilocybin

Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report.

Kelmendi B, Kichuk SA, DePalmer G +4

Europe PMC2022
PreprintPsilocybin

Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355

Ching THW, Kichuk S, DePalmer G +2

Europe PMC2022